Academic history
Tariq Mughal is a Professor of Hematology/Oncology in Tufts University School of Medicine, Boston, MA, and Buckingham University Medical School, Buckingham, UK. He received his medical degree from St George’s Hospital Medical School, London, UK, after which he completed postgraduate training in hematology, medical oncology and stem cell transplantation at Imperial College London, London, UK, and the University of Colorado School of Medicine, Denver, CO.
Prof. Mughal is also the founder of the Alpine Oncology Foundation, which has provided access to educational support and therapies for leukemias for developing nations worldwide. He additionally serves as an editorial board member of several peer-led hematology and oncology journals and was the founding Co-Editor of Clinical Leukemia.
Speaking on precision medicine for hematologic malignancies
Prof. Mughal’s principal research interests are in precision cancer medicine and hematological malignancies, melanoma and breast cancer. His research has led to the identification of novel gene fusions in childhood B- and T-acute lymphoblastic leukemia and acute myeloid leukemia (AML). In addition to his research, Prof. Mughal has written various books on leukemias, myelomas and lymphomas.
Prof. Mughal’s recent research has involved reviewing novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies, as well as discussing management of adolescent chronic myeloproliferative neoplasms.
